ibrutinib,
PCI 32765,
PCI-32765,
PCI32765,
PCI-32765 Racemate,
936563-87-0,
Ibrutinib Racemate,
PCI-32765 (Racemate),
PCI32765,
(S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one,
1-(3-(4-Amino-3-(4-phenyloxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one,
US8497277, 4,
US8497277, 13,
1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one,
1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one,
PCI32765 Racemate,
SCHEMBL201642,
BDBM1773,
CHEMBL3182647,
CHEBI:91397,
CTK8F8347,
SYN1171,
XYFPWWZEPKGCCK-UHFFFAOYSA-N,
BCPP000127,
HMS3656P11,
BCP02558,
BCP24087,
HY-10997A,
RW4153,
s2680,
AKOS026750227,
BCP9001055,
Bruton's Tyrosine Kinase Inhibitor III,
CS-2438,
EX-5965,
RL05884,
NCGC00387861-03,
AK133084,
AS-16305,
BC638848,
DB-079642,
FT-0721194,
US8476284, 4,
AB01565866_02,
BRD-A35869383-001-01-9,
Ibrutinib Racemate;PCI32765 Racemate;PCI 32765 Racemate,
936563-96-1 pound not PCI32765 pound not PCI 32765,
1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1yl)prop-2-en-1-one,
1-{3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one,
PCI-32765; 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3, 4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one,
Ibrutinib,
PCI-32765,
PCI-32765 (Ibrutinib),
936563-96-1,
cc-214,
C25H24N6O2,
PCI 32765,
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one,